Search results
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 6 hours agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 1 day agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 1 day agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 1 day agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 1 day agoSales of Padcev, a treatment for advanced bladder cancer Pfizer gained through its $43 billion deal...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 1 day agoThe revenue decline, as expected, was due to a steep drop in revenues from its COVID-19 products,...
TIME100 Health: Katalin Kariko and Drew Weissman
Time via Yahoo News· 9 hours agoIn under a year, both Pfizer-BioNTech and Moderna developed mRNA-based COVID-19 vaccines based on Kariko and Weissman ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 2 hours agoModerna added that clinical development and manufacturing expenses also decreased, driven by lower...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 2 days agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...